Cryptobiotix
ActiveSummary
Cryptobiotix has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.7m and a net result of €1.8m. Equity is growing by about 94% per year across the filed financial years. Its solvency ranks better than 59% of 240 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
15-05
Gazette deed
Resignations: Aurélien Baudot (director) and Pieter Van den Abbeele (director)Appointments: AB Initio Management (director) and PVDA Biosciences (director) · Permanent representatives: Aurélien Baudot and Pieter Van den Abbeele7 facts ▸
- General meeting, 10-03-2026
- Director resignation, Aurélien Baudot (director (not named in the articles))
- Director resignation, Pieter Van den Abbeele (director (not named in the articles))
- Director appointment, AB Initio Management (director (not named in the articles))
- Permanent representative, Aurélien Baudot
- Director appointment, PVDA Biosciences (director (not named in the articles))
- Permanent representative, Pieter Van den Abbeele
24-07
Gazette deed
Amendment of the articlesPower of attorney · Share issue4 facts ▸
- General meeting, 17-07-2024
- Amendment of the articles, 5
- Power of attorney
- Share issue, 10000, “vermenigvuldiging met factor 100” (deed in Dutch)
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.